DNA methylation is assumed to be complementary on both alleles across the genome although there are exceptions, notably in regions subject to genomic imprinting. We present a genomewide survey of the degree of allelic skewing of DNA methylation with the aim of identifying novel differentially methylated regions (DMRs) associated primarily with genomic imprinting or DNA sequence variation acting in cis. We used SNP microarrays to quantitatively assess allele-specific DNA methylation (ASM) in amplicons covering 7.6% of the human genome following cleavage with a cocktail of methylation-sensitive restriction enzymes (MSREs). Selected findings were verified using bisulfite-mapping and gene expression analyses, subsequently tested in a second tissue from the same individuals, and replicated in DNA obtained from 30 parent-child trios. Our approach detected clear examples of allele-specific DNA methylation (ASM) in the vicinity of known imprinted loci, highlighting the validity of the method. In total 2,7045 (1.5%) of our 183,605 informative and stringently filtered SNPs demonstrate an average relative allele score (RAS) change ≥0.10 following MSRE digestion. In agreement with previous reports, the majority of ASM (~90%) appears to be cis in nature, and several examples of tissue-specific ASM were identified.
INTRODUCTION
DNA methylation is a key epigenetic mechanism involved in the developmental regulation of gene expression 1 . Alterations in DNA methylation are known to contribute to inter-individual phenotypic variation and have been linked to the onset of cancer 2 and complex disease phenotypes such as major psychosis 3 . Across the majority of the genome, DNA methylation is assumed to be complementary on both alleles, although there are several instances where it can be allele-specific. . X-inactivation in any given cell is typically random, and is maintained once established so that the inactivated allele is transcriptionally silenced.
Examples of a third type of ASM have been recently reported, whereby genotype exerts an influence upon DNA methylation in cis 7-9 . Such patterns have been postulated to provide a mechanism behind the common allele-specific expression (ASE) differences observed throughout the genome [10] [11] [12] [13] [14] [15] , and provide a functional role for seemingly synonymous DNA sequence changes.
Several examples of ASM occurring in cis with genotype have been uncovered on chromosome 21 9, 16, 17 , and recent evidence suggests that genotype-associated ASM is common in both human and mice 7, 8 . Cis effects on gene expression, mediated by ASM, have been widely identified in malignant cells 18 , but the degree to which they operate in normal cellular systems has yet to be systematically ascertained.
In this study we applied an informative enrichment strategy and high-resolution microarrays to assess the full extent of human genomic ASM. We report numerous examples of allelically-skewed DNA methylation across the genome; whilst the majority appear to be cis in nature we also uncover novel DMRs where ASM is mediated by parental origin. We report several examples of tissue-specific ASM, and show that many ASM-associated SNPs are linearly associated with gene expression.
MATERIALS AND METHODS

Samples
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The initial sampling frame for our genome-wide ASM screen was the Twins Early Development Study (TEDS), a longitudinal study of behavioural development in a representative sample of twins born in 1994, 1995 and 1996 who have been followed from infancy through adolescence 19 . All twins and parents involved in TEDS provide informed consent for each stage of the study. Ethical approval for the Twins Early Development Study has been provided by the King's College London (UK) ethics committee. From a sample of healthy pairs of 12-year-old monozygotic (MZ) twins, five pairs were selected -four female pairs and one male pair (n=10). Venous blood samples were obtained from each individual and used to prepare both DNA and RNA using standard protocols. In addition, 3mL blood was collected from each subject to assess differences in cell sub-type compositions that may influence inter-individual expression profiles. All cell sub-type counts were in the normal range and comparable across subjects. Finally, buccal swabs were obtained from each individual and used to prepare DNA from a second tissue 20 .
GenomeͲwide analysis of ASM
For each individual, Affymetrix SNP 6.0 arrays (Affymetrix, UK) were used to genotype a) standard genomic DNA (G), b) DNA digested with a cocktail of MSREs (D), and c) whole-genome amplified fully unmethylated DNA digested with a cocktail of methylation-sensitive restriction enzymes (MRSEs) (U) (to control for the effect of SNPs at enzyme cleavage sites). 1μg of DNA from each individual was digested using a cocktail of three MRSEs: HpaII (5'-C^C G G-3'), HhaI (5'-G C G^C-3'),
and AciI (5'-C^C G C-3') that in combination interrogate the methylation status of ~32.4% of CpG sites in the human genome 21 . Unmethylated DNA from each individual was produced by wholegenome amplifying 100ng DNA using the Qiagen RepliG kit (Qiagen, Crawley, UK) using the manufacturer's protocol.
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Analysis of ASM microarray data
To enable us to quantitatively measure the degree of ASM we applied novel analytical techniques originally developed to assess SNP allele frequencies in DNA pools 22, 23 , which allowed us to accurately identify allelic skewing in addition to allelic switching following MSRE digestion. In order to compare arrays hybridised with uncut genomic DNA (G), to those hybridized with MSREdigested (D) or artificially demethylated and then MSRE-digested (U) DNA, we scaled the raw intensities for each array by a constant to bring the mean of the .90 to .95 quantiles to the same value as the mean of these quantiles for the U arrays. The rationale here was that the strongest signals on the U arrays would be from amplicon fragments without MSRE sites, and these should be equal across all arrays. At the same time the very highest few percentile may be enriched in artefacts and therefore more variable. Because they are expected to have differing distributions, each of the G, D, and U groups was subsequently individually quantile normalized. Relative allele score (RAS) values were generated using an updated version of our SNPMaP package (v1.02) in R
22
, developed specifically for these analyses, and available for download (see Web Resources). RAS is defined as A/(A + B), where A and B are the intensities of the probes for the two alleles for a given SNP, and has been validated as an accurate estimator of allele frequency in pools of DNA 23 . For a given SNP in a heterozygous individual, a difference in RAS score between G and D arrays is indicative of ASM.
We applied a highly-stringent filtering process to remove SNPs located in non-informative amplicons (Supplementary Table 1 and Supplementary Figure 1) , and processed artificially unmethylated DNA from each individual in parallel to control for polymorphic MSRE sites.
Amplicon fragment coordinates were obtained from the Affymetrix annotation file GenomeWideSNP_6.na27.annot.csv (corresponding to UCSC hg18), downloaded from the Affymetrix website (see Web Resources). Fragment sequences were downloaded using Galaxy (see Web Resources) and searched to identify those with one or more MSRE cut-sites. Because the Affymetrix 6.0 assay involves preparing both NspI and StyI amplicons, SNPs can be on one or two fragments, each of which can have an MSRE site. There are thus five classes of SNPs potentially generated by our approach: a (one amplicon generated (StyI or NspI) with a MSRE cut-site), b (two amplicons generated (StyI and NspI) both containing a MSRE cut-site), c (one amplicon generated (StyI or NspI) with no MSRE cut-site), d (two amplicons generated (StyI and NspI) with neither containing a MSRE cut-site), and e (two amplicons generated (StyI and NspI) with only one containing a MSRE cut-site) (Supplementary Table 1 ). As expected, plotting intensity ratios for the five classes of SNP from our normalized microarray data demonstrates that informative SNPs (class a and class b) have different U/G signal ratios compared to non-informative SNPs (class c, class d, and class e) (Supplementary Figure 1) . In addition to selecting only informative SNPs, we also required that SNPs were heterozygous in at least one MZ twin-pair, did not show genotype discordance within MZ-twin pairs, and passed a standard quality threshold across all arrays.
Finally, SNPs yielding a variable U/G ratio (SD > 0.07) across all samples were removed to further control against inaccurate measures of ASM due to possible DNA sequence / copy-number variation polymorphisms. Raw data and a UCSC browser track showing the amplicon fragments and their informativeness in this assay is available for viewing and download from our group webpage (see Web Resources).
Verification of microarray data
8
In order to verify data from the microarray analyses, ten SNPs showing high RAS changes indicative of ASM were subsequently tested using independent SNP-specific genotyping methods. Genomic DNA and unmethylated (whole-genome amplified) DNA from the same 10 individuals was independently digested with MSREs as described above. In addition to whole-blood DNA, we also processed buccal cell DNA from each individual to assess the tissue-specificity of any allelicallyskewed DNA methylation. PCRs were designed to span the SNP and any potentially-informative MSRE cut-sites within the NspI / StyI amplicons used in the Affymetrix protocol (Supplementary Table 2 ). SNP genotype was quantitatively assessed using the ABI SNaPshot Single Nucleotide Primer Extension assay followed by shrimp alkaline phosphatase (SAP) treatment and electrophoresis on an ABI 3300 (Applied Biosystems, Foster City, CA) using the manufacturer's protocol.
DNA methylation analysis across verified regions
DNA methylation at MSRE cut-sites located in the Affymetrix PCR amplicons containing the SNPs selected for verification was initially assessed using Methylation-Sensitive Single Nucleotide Primer Extension (MS-SNuPE) as described by Kaminsky et al 24 . Briefly, 500ng of genomic DNA was treated with sodium bisulfite as previously described 3 , and amplified using bisulfite-PCR. The ABI SNaPshot assay was used to quantify the relative proportion of DNA molecules methylated at each potential cut-site using the ABI SNaPshot Single Nucleotide Primer Extension assay followed by SAP treatment and electrophoresis on an ABI 3300 (Applied Biosystems, Foster City, CA) as described above. All bisulfite-based analyses included fully methylated and fully unmethylated control samples to ensure the validity of our data. Bisulfite primer sequences are presented in 25 . All data was tested for complete sodium bisulfite conversion, with an overall conversion rate >99.9% estimated by BiQ Analyzer.
Supplementary
Replication of selected ASM effects in independent samples
We obtained 90 enabling us to infer both parental-origin and cis ASM effects. An aliquot of each sample was digested to completion with a cocktail of MSREs as described above. SNP genotype was quantitatively assessed in both undigested and digested samples using the ABI SNaPshot Single Nucleotide Primer Extension assay followed by SAP treatment and electrophoresis on an ABI 3300 (Applied Biosystems, Foster City, CA) as described above.
Gene expression analysis
Given that DNA methylation is linked to the regulation of gene expression 1 , we postulated that ASM-associated SNPs may be linearly associated with the expression of nearby genes. Reliable estimates of gene expression were obtained from the same samples by profiling whole blood mRNA from each individual four times over a 10-month period 26 . Total RNA was obtained using
AlleleͲspecific DNA methylation 10 the PAXgene blood RNA Kit protocol (PreAnalytiX GmbH, Germany). Expression profiles were generated by hybridizing cRNA derived from 5μg of total RNA to Affymetrix U133 Plus 2.0 Arrays (Affymetrix, Santa Clara, CA) in accordance with the Affymetrix Eukaryote One-Cycle protocol with integrated globin reduction. Microarray data is MIAME compliant and is available to download at the Gene Expression Omnibus website (see Web Resources) under the accession number GSE14844.
RESULTS
Methodological Overview
A graphical overview explaining our methodological approach is given in Figure 1 and specific details are given in the Materials and Methods section (above). Briefly, using whole blood DNA from 10 individuals in 5 MZ twin-pairs, with co-twins serving as independent genetically-identical biological replicates, we employed high-resolution microarrays to quantitatively assess changes in relative allele signal at ~1 million SNPs following digestion with MRSEs. We applied a highlystringent filtering process to remove SNPs located in non-informative amplicons, and processed artificially unmethylated DNA from each individual in parallel to control for polymorphic MSRE sites. To enable us to quantitatively measure the degree of ASM we applied novel analytical techniques originally developed to assess SNP allele frequencies in DNA pools 22, 23 , allowing us to accurately identify allelic skewing in addition to complete allelic switching across the population of DNA molecules present in each sample following MSRE digestion. In order to confirm data from the microarray analyses, ten SNPs showing high RAS changes indicative of ASM were subsequently tested using independent SNP-specific genotyping methods. Selected findings were independently verified in a second cell-type (buccal) from the same individuals, and replicated in 90 familial DNA samples obtained from the CEPH pedigrees. DNA methylation across multiple ASM-associated regions was assessed using bisulfite-mapping to confirm that our observations resulted from differential methylation. Finally, using RNA samples from the same initial set of subjects we tested to see whether ASM-associated SNPs are also associated with gene expression changes. AlleleͲspecific DNA methylation 12 is noticeable that at least (9.7%) of ASM-associated SNPs in our study show some inconsistency in skewing, indicating they are unlikely to be cis in nature. In reality, this proportion is likely to be higher given that some non-cis ASM effects may go in the same direction across all heterozygous individuals by chance in the samples we processed.
GenomeͲwide patterns of ASM
Verification of microarray data and replication in additional samples
We selected ten ASM-associated SNPs from our microarray screen for independent verification and further investigation. Individual examples are discussed in detail in the sections below, but in all cases we were able to confirm the results of the microarray analysis, suggesting that our approach and stringent filtering techniques provide an accurate representation of patterns of ASM across the genome. MS-SNuPE analyses on bisulfite-treated DNA from the same individuals also uncovered patterns of DNA methylation consistent with ASM. Six loci were selected for replication analysis in DNA obtained from 30 CEPH family trios. In each case we were able to verify the patterns of ASM observed in our initial set of samples. The large number of samples in this replication stage, in conjunction with the availability of parental genotype information, allowed us to determine whether ASM was associated with genomic sequence in cis, or was influenced by parental origin. Finally, we performed in-depth clonal bisulfite sequencing, considered the 'goldstandard' method for assessing allelic patterns of DNA methylation, across four regions. Again these analyses confirmed the patterns of ASM predicted from our microarray screen and subsequent verification experiments.
Testing the validity of our approach -confirming ASM at known imprinted regions Figure 3) . Finally, we replicated the pattern of genotype-independent ASM at this region in samples obtained from 30 CEPH family trios, confirming that DNA methylation occurs specifically on the maternally-inherited allele (see Figure 2E ).
Our approach detected clear examples of ASM in the vicinity of other known imprinted loci (Table   2A) . These include large RAS changes for SNPs located near H19, including several in the vicinity of the H19-DMR located ~2kb upstream of the transcriptional start site. This region is known to act as a boundary element, instigating monoallelic expression across a cluster of genes on 11p15 via interactions with the vertebrate insulator protein, CCCTC-binding factor 27 . Several other large RAS changes were identified in the 11p15 region including at SNP_A-4258853 (rs4758622), which provides evidence for strong allelic-skewing of DNA methylation in the first intron of NAP1L4.
Contradictory evidence exists about whether the mouse homologue of this gene (Nap1l4) is imprinted 28 , and its status in humans is unknown. Intriguingly, our data suggest that the allele-
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14 specific methylation at this region is not due to imprinting but may be caused by cis-acting genetic effects (Supplementary Figure 4) . Figure 5B) , a conclusion confirmed by our SNuPE verification experiments with the average G/A allelic ratio switching from 1.9 in heterozygous genomic DNA samples to 2.5 in MSRE-digested heterozygous samples.
One of the loci selected for further investigation demonstrates evidence for parent-of-origin mediated ASM in a genomic region not previously known to be imprinted. SNP_A-1782879 (rs17427250), located at 5q34 upstream of ATP10B and downstream of GABRB2, was found to have an average RAS change of 0.30 in heterozygous individuals ( Figure 3A and Figure 3B ), an observation confirmed by SNuPE analysis ( Figure 3C ). Interestingly, this ASM appears to be tissuespecific; our original analyses on blood DNA highlights almost complete loss of one allele following MSRE digestion in heterozygotes; this is not the case in buccal-cell DNA from the same individuals ( Figure 3C ). Clonal bisulfite sequencing across this region in blood confirms a pattern of biphasic DNA methylation at an AciI cut-site ( Figure 3D ). Direct bisulfite sequencing found this site to be consistently hemi-methylated in blood DNA but fully methylated in buccal DNA obtained from the same individuals ( Figure 3E ). Loss of heterozygosity following MSRE digestion was confirmed in the 30 CEPH trios, with different alleles being cleaved in different individuals ( Figure 3F ). Such a pattern of allelic-flipping is consistent with genomic imprinting, and we confirmed using parental genotypes that it is the paternally-inherited allele that is always cleaved (unmethylated). It has been previously shown that many imprinted regions show marked changes in DNA methylation during development and can acquire tissue-specific ASM 30 .
CisͲregulated ASM effects
Several examples of ASM at non-imprinted loci, presumably occurring because of cisͲacting genotypic effects on DNA methylation, have been previously reported 8, 9 . We confirmed many of these previously identified examples using our approach, again highlighting the validity of our screening methods (Table 2B and Figure 4 ). In many instances the high density of informative SNPs in our study, afforded by the use of multiple MSREs and a high-resolution microarray platform, allowed more specific localisation of these previously identified ASM effects. For example, a region located in intron 13 of the LTF gene on chromosome 3p21.31, and within 1kb of another SNP and SNP_A-1876897 (rs6441992) (see Figure 5A and Figure 5B ). Genotype associated ASM at LTF SNPs was confirmed using SNuPE analyses ( Figure 5C and Figure 5D ), and replicated in the CEPH family DNA from 30 trios ( Figure 5E and Figure 5F ). At both SNP_A-1972595 (rs6441990) and SNP_A-2149420 (rs6441991) we observe a highly significant change in allele ratio after MSRE digestion in heterozygous individuals confirming a cis effect on ASM. , and our data suggest that such heterogeneity may be mediated by epigenetic differences. Evidence to support the notion that the expression of OPCML is regulated by genotype-associated ASM comes from our transcriptomic data on the same set of blood samples; C/C homozygotes show significantly higher expression than C/T heterozygotes ( Figure 7F ). Interestingly, loss of OPCML expression in ovarian cancer (MIM 167000) has been previously associated with increased CpG methylation in the gene 32 .
ASMͲassociated SNPs and gene expression
Given that DNA methylation is linked to the regulation of gene expression 1 , we postulated that any cis-acting ASM-associated SNPs may be linearly associated with the expression of nearby genes.
Reliable estimates of gene expression were obtained from the same samples by profiling whole blood mRNA from each individual four times over a 10-month period (see Materials and Methods). Of the 2,704 informative SNPs with a RAS change ≥0.10, 651 map to within 5kb of a gene expressed at detectable levels in blood. Samples were grouped by genotype for each SNP, and transcript levels across genotype groups assessed using a linear effects model for each probeset. Because some SNPs are located within 5kb of more than one gene, and each gene can be represented by more than one expression probe-set, 1,316 such SNP/expression associations were tested. Strikingly, 214 (16.3%) provided evidence for a significant (p<0.05) linear association between genotype and transcript abundance, confirming the notion that many of the ASM effects we detect correlate with allelic expression differences that are likely to be cis in nature (Supplementary Table 3 C12orf47. Out of the ASM regions detected in our study for which there was previous evidence of ASM (see Table 2B and Figure 4) , reliable levels of expression in blood were only obtained for COL18A in which SNP_A-2020619 (rs2236472) has an average RAS change of 0.27 across heterozygous individuals. Interestingly, genotype is significantly associated with transcript abundance (Figure 9) , suggesting a cis-acting effect on gene expression that is mediated by ASM. Five lines of evidence confirm that our microarray-based screen of allelic changes following MSRE digestion is tagging real allelic differences in DNA methylation. First, as described under Materials and Methods, we have taken an extremely stringent approach to data analysis in order to avoid false-positive observations. In addition, we included parallel analyses of fully-unmethylated DNA samples from the same individuals to overcome the confounding effect of polymorphic SNPs in MSRE cut-sites. Second, many of the regions identified as showing large changes in RAS following MSRE digestion in our microarray screen are located either in the vicinity of DMRs associated with known imprinted loci or near regions previously nominated as containing cis-acting variants associated with ASM (see Table 2 ). Third, we have succeeded in verifying each of ten selected ASM-associated SNPs using a second quantitative genotyping method on the same samples.
Fourth, we replicated these findings in an independent set of 30 CEPH family trios (90 individuals);
the relatively large number of replication samples, and their familial nature meant we could deduce whether ASM patterns at each locus were due to cis effects of genotype or parental origin influences (i.e. genomic imprinting). Finally, we directly assessed DNA methylation across relevant . Our data, demonstrating that polymorphisms can exert an effect on gene function via epigenetic processes such as ASM occurring in cis, suggest a common pathway behind both genetic and environmental effects and a potential mechanism for G X E interaction.
Our findings indicate that a comprehensive epigenetic analysis of candidate SNPs and haplotypes is warranted and that integrating genome-wide ASM screens into current GWA strategies may be a useful approach. The ASM dataset produced in this study represents an essential first step towards this approach, and the web-resource we have developed can be used by the GWA research community to aid in the interpretation of apparently non-functional sequence changes that are associated with disease.
To conclude, we performed a systematic screen of allele-specific DNA methylation across the genome with the aim of identifying novel differentially methylated regions associated with either genomic imprinting or DNA sequence variation. We employed high-resolution microarrays, and a novel analytical approach to quantitatively assess changes in relative allele signal (RAS) at ~1 million SNPs following digestion with methylation-sensitive restriction enzymes (MRSEs). Taken together, our data show that ASM is widespread (occurring at >35,000 sites across the genome) and likely to be associated with both parental-origin and cis-effects on gene expression. Using RNA from the same blood samples, we were able to linearly correlate ASM with gene expression, and using a second source of DNA from each individual, we were able to identify several examples of tissue-specific ASM. Our data suggests that a spectrum of ASM is likely, with heterogeneity between individuals and across tissues. These findings impact upon our understanding about the 
Outline of the experimental approach used to identify alleleͲspecific DNA methylation (ASM).
Genomic DNA samples were digested with a cocktail of three methylation-sensitive restriction enzymes (MSREs). In parallel, artificially unmethylated DNA from each individual was digested using the same cocktail of enzymes to act as a control for the effect of genetic variation at MSRE In total, >16% of loci demonstrating a change in RAS >0.10 following MSRE digestion, for which reliable expression data is available, show a significant linear association between genotype and transcript abundance. 
Evidence of cisͲacting ASM at SNP_AͲ8638885 (rs10148112). A) This SNP is located between
CYP46A1 and EML1 on chromosome 14q32.2 and B) shows consistent loss of allele C following MSRE digestion, C) subsequently confirmed by SNuPE analysis.
Supplementary Figure 7.
Evidence of cisͲacting ASM at SNP_AͲ1795087 (rs8179387). A) This SNP is located between HSPG2
and CELA3B on chromosome 1p36.12 and B) shows consistent loss of allele G following MSRE digestion, C) subsequently verified by SNuPE. Signal ratio density plots for unmethylated MSREͲdigested (U) samples against uncut genomic DNA (G) for the 5 classes of SNP on the Affymetrix V6 array: a = one amplicon generated (StyI or NspI) with a MSRE cut-site; b = two amplicons generated (StyI and NspI) both containing a MSRE cut-site; c = one amplicon generated (StyI or NspI) with no MSRE cut-site; d = two amplicons generated (StyI and NspI) with neither containing a MSRE cutsite; and e = two amplicons generated (StyI and NspI) with only one containing a MSRE cutsite. We included only a and b in our ASM analyses. This figure highlights the different distribution observed in the 'informative' SNPs (a and b) compared to the fully noninformative SNPs (c and d), with an intermediate distribution for the semi-informative SNPs (e), supporting the validity of our method. Supplementary Table 2 Primer sequences used in our independent verification reactions. 
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